32 phenotypes from 4 alleles in 6 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Cers1fln/Cers1fln NOD.Cg-Cers1fln/Sz	abnormal lipid homeostasis	J:172719
	abnormal lipid level	J:172719
	abnormal Purkinje cell dendrite morphology	J:172719
	ataxia	J:172719
	decreased body size	J:172719
	hyperactivity	J:172719
	lipofuscinosis	J:172719
	normal mortality/aging	J:172719
	neuron degeneration	J:172719
	Purkinje cell degeneration	J:172719
	weight loss	J:172719
Cers1fln/Cers1to involves: BALB/c * C57BL/Ka * FVB/N * NOD	ataxia	J:172719
	Purkinje cell degeneration	J:172719
Cers1tm1.1Kwi/Cers1tm1.1Kwi involves: 129P2/OlaHsd * C57BL/6	abnormal anxiety-related response	J:193419
	abnormal lipid homeostasis	J:193419
	abnormal lipid level	J:193419
	abnormal motor learning	J:193419
	abnormal response to novel object	J:193419
	abnormal spatial working memory	J:193419
	astrocytosis	J:193419
	cerebellum atrophy	J:193419
	cerebellum vermis hypoplasia	J:193419
	decreased locomotor activity	J:193419
	decreased Purkinje cell number	J:193419
	increased neuron apoptosis	J:193419
	lipofuscinosis	J:193419
	Purkinje cell degeneration	J:193419
	reduced cerebellar foliation	J:193419
Cers1tm1b(EUCOMM)Hmgu/Cers1+ C57BL/6N-Cers1tm1b(EUCOMM)Hmgu/H	increased neutrophil cell number	J:211773
Cers1tm1b(EUCOMM)Hmgu/Cers1tm1b(EUCOMM)Hmgu C57BL/6N-Cers1tm1b(EUCOMM)Hmgu/H	preweaning lethality, incomplete penetrance	J:211773
Cers1to/Cers1to either: FVB/N or (involves: C3H * C57BL/6J * FVB/N)	abnormal Purkinje cell dendrite morphology	J:91243
	ataxia	J:91243
	decreased body weight	J:91243
	decreased brain weight	J:91243
	gliosis	J:91243
	impaired balance	J:91243
	premature death	J:91243
	Purkinje cell degeneration	J:91243
	seizures	J:91243
	small cerebellum	J:91243
	tremors	J:91243
Cers1to/Cers1to FVB/N-Cers1to	abnormal Purkinje cell dendrite morphology	J:172719